Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $2.8400 (-12.48%) ($2.8400 - $2.8400) on Sat. May. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.77% (three month average) | RSI | 27 | Latest Price | $2.8400(-12.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -1.9% a day on average for past five trading days. | Weekly Trend | AUTL declines -5.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting AUTL price | AUTL will decline at least -1.885% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.885% (StdDev 3.77%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-19.26(-778.17%) | Resistance Level | $3.52 | 5 Day Moving Average | $3.17(-10.41%) | 10 Day Moving Average | $3.21(-11.53%) | 20 Day Moving Average | $3.52(-19.32%) | To recent high | -39.3% | To recent low | 0% | Market Cap | $N/A | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |